ClinicalTrials.Veeva

Menu

The Effect of Percutaneous Dilatational Tracheostomy on Intracranial Pressure

A

Akdeniz University

Status

Active, not recruiting

Conditions

Intracranial Pressure Change
Tracheostomy

Treatments

Diagnostic Test: The optic nerve sheath diameter measurement method by ultrasonography
Procedure: Percutaneous dilatational tracheostomy

Study type

Observational

Funder types

Other

Identifiers

NCT06779877
AkdenizU.

Details and patient eligibility

About

Percutaneous dilatational tracheostomy (PDT) is a common bedside alternative to surgical tracheostomy in intensive care unit patients. Intracranial pressure measurement is a vital parameter that should be monitored when performing any procedure including PDT in these patients. During PDT, changes in intracranial pressure may occur depending on the position applied, hypercarbia and hypertension that may develop during the procedure. However, the effect of PDT procedure on intracranial pressure is controversial. It is imperative to ascertain the impact of PDT on intracranial pressure, along with the factors that influence its fluctuations during the procedure. This is of particular significance in order to avert the occurrence of deleterious conditions that may be engendered by elevated intracranial pressure. The aim of current study was to evaluate the effect of PDT procedure on intracranial pressure.

Full description

Since the study is a prospective observational study, the investigators will not be the decision-making physicians about the treatments applied to the patients. The optic nerve sheath diameter measurement method by ultrasonography will be used to determine intracranial pressure.Intracranial pressure measurement will be performed in neutral position before PDT, after the patient is positioned for the procedure, immediately after the procedure and immediately after the patient is placed in neutral position. Demographic characteristics, comorbidity status, PDT indication, intensive care unit hospitalisation diagnosis, intracranial pathology data, haemodynamic data, arterial blood gas parameters will be recorded.

Enrollment

35 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical indication for PDT

Exclusion criteria

  • Age <18
  • Patients with glaucoma
  • Patients with optic nerve damage
  • Patients in whom PDT is contraindicated (coagulopathy, infection at the site of intervention, etc.)

Trial design

35 participants in 2 patient groups

Patients without intracranial pathology
Description:
Patients undergoing PDT who have been shown to have no intracranial pathology by any imaging procedure
Treatment:
Diagnostic Test: The optic nerve sheath diameter measurement method by ultrasonography
Procedure: Percutaneous dilatational tracheostomy
Patients with intracranial pathology
Description:
Patients undergoing PDT who have been shown to have intracranial pathology by any imaging procedure
Treatment:
Diagnostic Test: The optic nerve sheath diameter measurement method by ultrasonography
Procedure: Percutaneous dilatational tracheostomy

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems